Filing Details
- Accession Number:
- 0001077183-19-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-28 17:05:58
- Reporting Period:
- 2019-02-26
- Accepted Time:
- 2019-02-28 17:05:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1621453 | J. Robert Shovlin | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | President, Clinical Services | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-26 | 119,348 | $7.15 | 242,739 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-02-26 | 66,666 | $7.52 | 309,405 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-26 | 141,879 | $18.88 | 167,526 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 44,135 | $19.23 | 123,391 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-02-28 | 13,986 | $7.15 | 137,377 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-26 | 119,348 | $0.00 | 119,348 | $7.15 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-28 | 13,986 | $0.00 | 13,986 | $7.15 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-26 | 66,666 | $0.00 | 66,666 | $7.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
80,652 | 2017-04-20 | 2021-04-20 | No | 4 | M | Direct |
66,666 | 2017-04-20 | 2021-04-20 | No | 4 | M | Direct |
133,334 | 2018-04-28 | 2022-04-28 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $8.03 | 2019-02-26 | 2023-02-26 | 288,500 | 288,500 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2023-02-26 | 288,500 | 288,500 | Direct |
Footnotes
- On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.